Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise
Deep News
Feb 10
Shares of innovative drug concept companies advanced broadly before the midday break. At the time of writing, CSPC PHARMA (01093) was up 7.16%, trading at HK$10.48. WUXI BIO (02269) rose 5.54% to HK$40.36. Additionally, other biopharmaceutical stocks also registered gains.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.